Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study

NCT01914159 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT01914159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01914159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study
Lead sponsor
University Hospital, Bonn
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2013
Completion date
March 31, 2016
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration